A detailed history of Xml Financial, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Xml Financial, LLC holds 14,500 shares of IOVA stock, worth $118,610. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,500
Previous 13,500 7.41%
Holding current value
$118,610
Previous $108,000 25.93%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$7.28 - $11.9 $7,280 - $11,900
1,000 Added 7.41%
14,500 $136,000
Q2 2024

Jul 22, 2024

BUY
$7.78 - $14.19 $3,890 - $7,095
500 Added 3.85%
13,500 $108,000
Q1 2024

May 15, 2024

BUY
$7.59 - $17.47 $98,670 - $227,109
13,000 New
13,000 $192,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.29B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Xml Financial, LLC Portfolio

Follow Xml Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xml Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xml Financial, LLC with notifications on news.